sputnik v
- NewsBy Carlos Santamaria, Alex Kliment and Willis SparksPublished April 27, 2021
- ask ian
Israel's highly charged election; EU-China deal at risk over sanctions
Ian Bremmer discusses Israel's election, the EU-China tensions over sanctions, and Putin's jab on this edition of World In 60 Seconds.
By GZERO StaffPublished March 23, 2021
- Puppet Regime
The drug deal of the century
When the EU can't get the fix it needs, Angela Merkel turns to desperate measures.
By GZERO StaffPublished February 24, 2021
- News
The Graphic Truth: Russia's bid to vaccinate the world
While multiple Western countries ramp up coronavirus vaccinations with the Pfizer and Moderna jabs, Vladimir Putin's Sputnik V gamble is now paying off as developing nations increasingly turn to Russia's cheaper yet equally effective vaccine to inoculate their populations. Sputnik V — one of only three jabs which is more than 90 percent effective against severe COVID cases — has already been approved for use in almost 30 countries, most of them longtime Russian allies but also a host of other nations — like for instance Hungary or Mexico — that aim to hedge their bets if supplies of other jabs dry up. If the trend continues, can Russia win the global vaccine race against the West and China? We take a look at where Sputnik V has been approved for use or domestic production, and how many doses will be distributed and manufactured in each country.
By Carlos Santamaria and Paige ParsacalaPublished February 17, 2021 Dive deeper with our top stories and analysis.
Privacy notice: By signing up, I acknowledge that I have read, understand, and consent to the Privacy Policy and Terms of Use, including the transfer of my personal data to the United States from my country of residence (if different).
